Apieron (Menlo Park, CA) a commercial-stage medical device company and developer of an exhaled nitric oxide monitor for the management of asthma, closed a $XM Series D financing. Participants include Onset Ventures, Alliance Technology Ventures, Canaan Partners and Draper Fisher Jurvetson.

*Investment amt undisclosed by by company